Recursion Pharmaceuticals, Inc. (RXRX) Revenue by Year
Recursion Pharmaceuticals, Inc. generated $74.7M in revenue in fiscal year 2025. This represents an increase of 26.9% from the prior fiscal year. Over the trailing 12 months, Q3 FY2025 through Q2 FY2026, the same line adds up to $54.9M in revenue. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters Recursion Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
RXRX Revenue by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
TTM is the trailing twelve months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
RXRX Revenue by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
What revenue means
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.
More Recursion Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Recursion Pharmaceuticals, Inc.'s revenue in fiscal year 2025?
Recursion Pharmaceuticals, Inc. generated $74.7M in revenue in fiscal year 2025.
How fast is Recursion Pharmaceuticals, Inc.'s revenue growing?
Recursion Pharmaceuticals, Inc. (RXRX) revenue rose by 26.9% year over year, from $58.8M to $74.7M in fiscal year 2025.
What is Recursion Pharmaceuticals, Inc.'s revenue over the last twelve months?
Recursion Pharmaceuticals, Inc. (RXRX) reported $54.9M in revenue over the trailing 12 months, Q3 FY2025 through Q2 FY2026, summed from the four most recent quarterly filings.
How has Recursion Pharmaceuticals, Inc.'s revenue changed over the years?
Across the 7 fiscal years this page covers, Recursion Pharmaceuticals, Inc. (RXRX) revenue went from $2.3M in fiscal year 2019 to $74.7M in fiscal year 2025.
What was Recursion Pharmaceuticals, Inc.'s revenue in the most recent quarter?
Recursion Pharmaceuticals, Inc. (RXRX) reported $7.7M in revenue in Q2 2026. This represents a decrease of 60.1% from the same quarter a year earlier.
What does revenue mean on a financial statement?
Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Recursion Pharmaceuticals, Inc. (RXRX) reported on that line in every period on record.